| UHC UMR Medical and Drug | Gene Therapies for Hemophilia B – Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Home Hemodialysis – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Hysterectomy – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Implanted Electrical Stimulator for the Spinal Cord – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Injectable Dermal Fillers and Bulking Agents – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Interspinous Fusion and Decompression Devices – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Ketalar® (Ketamine) and Spravato® (Esketamine) – Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Light and Laser Therapy – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Liposuction for Lipedema – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Luxturna® (Voretigene Neparvovec-Rzyl) – Commercial Medical Benefit Drug Policy | 2026-01-01 |